Lv3
390 积分 2024-06-09 加入
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
3个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
4个月前
已完结
Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita
9个月前
已完结
Fanconi Anemia Signaling and Cancer
9个月前
已完结
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair
9个月前
已完结
Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis
9个月前
已完结
Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis
9个月前
已完结
Fanconi anemia: realizing hematopoietic cure
9个月前
已完结
Diagnosis and Treatment of Chronic Lymphocytic Leukemia
9个月前
已完结
CAR T Cells and T-Cell Therapies for Cancer
9个月前
已完结
皖公网安备34019202002308
